furosemide has been researched along with Nephrocalcinosis in 45 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Nephrocalcinosis: A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether NPS R-467 could, like parathyroidectomy, prevent furosemide-induced nephrocalcinosis, we studied 35 6-week-old male Sprague-Dawley rats, divided into five groups." | 7.72 | Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Fox, J; Pattaragarn, A, 2004) |
| "Nephrolithiasis and nephrocalcinosis in low-birth-weight, preterm neonates are well-documented complications of furosemide administration." | 7.72 | Furosemide nephrolithiasis causing ureteral obstruction and urinoma in a preterm neonate. ( Alpert, SA; Noe, HN, 2004) |
| "The use of furosemide is well recognized as a predisposing factor of nephrocalcinosis in infants." | 7.71 | Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. ( Chung, SJ; Han, HJ; Huh, W; Kim, B; Kim, MK; Kim, YG; Lee, JY; Lee, KB; Lee, YH; Oh, HY; Ryu, JA, 2001) |
| "Furosemide (F)-induced nephrocalcinosis (NC) has been traditionally described in low birth weight premature infants." | 7.70 | Effect of age on furosemide-induced nephrocalcinosis in the rat. ( Alon, MM; Alon, US; Nichols, MA; Osorio, AV, 1998) |
| "In order to study the incidence and course of nephrocalcinosis in full-term infants with congestive heart failure receiving long-term furosemide treatment, 36 such infants (median age 2." | 7.70 | Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. ( Koivisto, M; Lanning, P; Paavilainen, T; Saarela, T, 1999) |
| "A previous study on furosemide-induced nephrocalcinosis (NC) showed only partial resolution of the calcifications after discontinuation of the diuretic." | 7.70 | Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Knoll, S, 2000) |
| "Nephrocalcinosis and nephrolithiasis developed in five children after furosemide therapy for congestive heart failure." | 7.69 | Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. ( Alon, US; Garola, RE; Scagliotti, D, 1994) |
| "The long-term prognosis of furosemide-associated nephrocalcinosis in the infant is still unclear." | 7.69 | Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Gratny, LL; Kaplan, RA; Nichols, MA, 1996) |
| "Furosemide treatment in the human neonate is associated with sodium depletion, growth retardation, hypercalciuria and nephrocalcinosis." | 7.69 | Salt supplementation, growth, and nephrocalcinosis in the furosemide-treated weanling rat. ( Alon, US; Gratny, LL; Hall, RT; Ringer, K, 1997) |
| "Early data indicate that nephrocalcinosis resolves in approximately 50% of premature infants 5 to 6 months after discontinuation of furosemide." | 5.08 | The natural history of nephrocalcinosis in premature infants treated with loop diuretics. ( Brock, JW; Klein, AM; Pope, JC; Trusler, LA; Walsh, WF; Yared, A, 1996) |
| " Furosemide should be cautiously prescribed in VLBW infants, and nutritional support must be well monitored to support postnatal growth and limit risk of nephrocalcinosis." | 4.12 | Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural course. ( Bacchetta, J; Fayard, J; Lorthois, S; Picaud, JC; Pradat, P, 2022) |
| " A 28-day-old neonate, presenting with SCFN, hypercalcemia and nephrocalcinosis was managed with intravenous saline followed by furosemide, oral prednisolone, potassium citrate and etidronate." | 3.73 | Subcutaneous fat necrosis with hypercalcemia. ( Nammalwar, BR; Prahlad, N; Shanmughasundharam, R; Vijayakumar, M, 2006) |
| "To determine whether NPS R-467 could, like parathyroidectomy, prevent furosemide-induced nephrocalcinosis, we studied 35 6-week-old male Sprague-Dawley rats, divided into five groups." | 3.72 | Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Fox, J; Pattaragarn, A, 2004) |
| "Nephrolithiasis and nephrocalcinosis in low-birth-weight, preterm neonates are well-documented complications of furosemide administration." | 3.72 | Furosemide nephrolithiasis causing ureteral obstruction and urinoma in a preterm neonate. ( Alpert, SA; Noe, HN, 2004) |
| "The use of furosemide is well recognized as a predisposing factor of nephrocalcinosis in infants." | 3.71 | Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. ( Chung, SJ; Han, HJ; Huh, W; Kim, B; Kim, MK; Kim, YG; Lee, JY; Lee, KB; Lee, YH; Oh, HY; Ryu, JA, 2001) |
| " The purpose of this study was to induce nephrocalcinosis (NC) in rabbits with phosphate, vitamin D, oxalate and furosemide, to determine the effect on renal function and to correlate detection on ultrasound (US) and computed tomography (CT) with pathology." | 3.70 | Nephrocalcinosis in rabbits--correlation of ultrasound, computed tomography, pathology and renal function. ( Cramer, B; Husa, L; Pushpanathan, C, 1998) |
| "Furosemide (F)-induced nephrocalcinosis (NC) has been traditionally described in low birth weight premature infants." | 3.70 | Effect of age on furosemide-induced nephrocalcinosis in the rat. ( Alon, MM; Alon, US; Nichols, MA; Osorio, AV, 1998) |
| "In order to study the incidence and course of nephrocalcinosis in full-term infants with congestive heart failure receiving long-term furosemide treatment, 36 such infants (median age 2." | 3.70 | Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. ( Koivisto, M; Lanning, P; Paavilainen, T; Saarela, T, 1999) |
| "A previous study on furosemide-induced nephrocalcinosis (NC) showed only partial resolution of the calcifications after discontinuation of the diuretic." | 3.70 | Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Knoll, S, 2000) |
| "Nephrocalcinosis and nephrolithiasis developed in five children after furosemide therapy for congestive heart failure." | 3.69 | Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. ( Alon, US; Garola, RE; Scagliotti, D, 1994) |
| "Furosemide treatment in the human neonate is associated with sodium depletion, growth retardation, hypercalciuria and nephrocalcinosis." | 3.69 | Salt supplementation, growth, and nephrocalcinosis in the furosemide-treated weanling rat. ( Alon, US; Gratny, LL; Hall, RT; Ringer, K, 1997) |
| "Nephrocalcinosis has been observed in premature infants treated with furosemide." | 3.68 | Furosemide increases total calcium in kidney and cytoplasmic free calcium in blood mononuclear cells of guinea pigs. ( Klip, A; Radde, IC; Tsao, PW, 1990) |
| " All 12 children but 2 continued to receive furosemide for their chronic lung disease demonstrating significant association between chronic use of loop diuretics and persistence fo the renal calcifications (p less than 0." | 1.28 | Furosemide-related renal calcifications in the premature infant. A longitudinal ultrasonographic study. ( Alon, U; Daily, DK; Downing, GJ; Egelhoff, JC, 1991) |
| "Renal calculi were seen in four patients, sonographically demonstrated as echogenic foci in the dependent portion of the collecting system, usually accompanied by acoustic shadowing." | 1.27 | Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy. ( Adelman, RD; Goetzman, BW; McGahan, JP; Myracle, MR, 1986) |
| "Moreover, a total 14 cases of pseudo-Bartter's syndrome reported in Japanese literature is reviewed." | 1.26 | Pseudo-Bartter's syndrome due to furosemide abuse: report of a case and an analytical review of Japanese literature. ( Isozaki, S; Nakayama, M; Sato, T; Tajiri, J; Uchino, K, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (20.00) | 18.7374 |
| 1990's | 19 (42.22) | 18.2507 |
| 2000's | 8 (17.78) | 29.6817 |
| 2010's | 6 (13.33) | 24.3611 |
| 2020's | 3 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fayard, J | 1 |
| Pradat, P | 1 |
| Lorthois, S | 1 |
| Bacchetta, J | 1 |
| Picaud, JC | 1 |
| Kriuchkova, N | 1 |
| Breiderhoff, T | 1 |
| Müller, D | 1 |
| Yilmaz, DE | 1 |
| Demirci, H | 1 |
| Drewell, H | 1 |
| Günzel, D | 1 |
| Himmerkus, N | 1 |
| Bleich, M | 1 |
| Persson, PB | 1 |
| Mutig, K | 1 |
| Conticini, E | 1 |
| Negro, A | 1 |
| Magnani, L | 1 |
| Ugolini, R | 1 |
| Atienza-Mateo, B | 1 |
| Frediani, B | 1 |
| Salvarani, C | 1 |
| El Maghraoui, J | 1 |
| Souilmi, FZ | 1 |
| Hbibi, M | 1 |
| Houssaini, TS | 1 |
| Hida, M | 1 |
| Gimpel, C | 1 |
| Krause, A | 1 |
| Franck, P | 1 |
| Krueger, M | 1 |
| von Schnakenburg, C | 1 |
| Chang, HY | 1 |
| Hsu, CH | 1 |
| Tsai, JD | 1 |
| Li, ST | 1 |
| Hung, HY | 1 |
| Kao, HA | 1 |
| Chang, JH | 1 |
| Chung, HY | 1 |
| Wang, HK | 1 |
| Uzu, T | 1 |
| Araki, S | 1 |
| Isshiki, K | 1 |
| Maegawa, H | 1 |
| Tuchman, S | 1 |
| Asico, LD | 1 |
| Escano, C | 1 |
| Bobb, DA | 1 |
| Ray, PE | 1 |
| Tseng, MH | 1 |
| Chu, SM | 1 |
| Cheng, CJ | 1 |
| Lien, R | 1 |
| Shih, IS | 1 |
| Lin, SH | 1 |
| Pattaragarn, A | 1 |
| Fox, J | 1 |
| Alon, US | 7 |
| Alpert, SA | 1 |
| Noe, HN | 1 |
| Vijayakumar, M | 1 |
| Prahlad, N | 1 |
| Nammalwar, BR | 1 |
| Shanmughasundharam, R | 1 |
| Pearse, DM | 1 |
| Kaude, JV | 1 |
| Williams, JL | 1 |
| Bush, D | 1 |
| Wright, PG | 1 |
| Becher, R | 1 |
| Löhren, D | 1 |
| Firusian, N | 1 |
| Tajiri, J | 1 |
| Nakayama, M | 1 |
| Sato, T | 1 |
| Isozaki, S | 1 |
| Uchino, K | 1 |
| Scagliotti, D | 1 |
| Garola, RE | 1 |
| Baggio, B | 1 |
| Gambaro, G | 1 |
| Marchini, F | 1 |
| Vincenti, M | 1 |
| Ceolotto, G | 1 |
| Pessina, AC | 1 |
| Semplicini, A | 1 |
| Pope, JC | 1 |
| Trusler, LA | 1 |
| Klein, AM | 1 |
| Walsh, WF | 1 |
| Yared, A | 1 |
| Brock, JW | 1 |
| Kaplan, RA | 1 |
| Gratny, LL | 2 |
| Nichols, MA | 2 |
| Ringer, K | 1 |
| Hall, RT | 1 |
| Campfield, T | 1 |
| Braden, G | 1 |
| Flynn-Valone, P | 1 |
| Powell, S | 1 |
| Cramer, B | 1 |
| Husa, L | 1 |
| Pushpanathan, C | 1 |
| Scales, JW | 1 |
| Krowchuk, DP | 1 |
| Schwartz, RP | 1 |
| Jorizzo, JL | 1 |
| Osorio, AV | 1 |
| Alon, MM | 1 |
| Saarela, T | 1 |
| Lanning, P | 1 |
| Koivisto, M | 1 |
| Paavilainen, T | 1 |
| Knoll, S | 1 |
| Moldavsky, M | 1 |
| Villanueva Lamas, J | 1 |
| Giménez Llort, A | 1 |
| Camacho Diaz, A | 1 |
| García García, L | 1 |
| Simões, A | 1 |
| Domingos, F | 1 |
| Prata, MM | 1 |
| Blanchard, A | 1 |
| Jeunemaitre, X | 1 |
| Coudol, P | 1 |
| Dechaux, M | 1 |
| Froissart, M | 1 |
| May, A | 1 |
| Demontis, R | 1 |
| Fournier, A | 1 |
| Paillard, M | 1 |
| Houillier, P | 1 |
| Kim, YG | 1 |
| Kim, B | 1 |
| Kim, MK | 1 |
| Chung, SJ | 1 |
| Han, HJ | 1 |
| Ryu, JA | 1 |
| Lee, YH | 1 |
| Lee, KB | 1 |
| Lee, JY | 1 |
| Huh, W | 1 |
| Oh, HY | 1 |
| Downing, GJ | 2 |
| Egelhoff, JC | 2 |
| Daily, DK | 2 |
| Thomas, MK | 1 |
| Alon, U | 2 |
| Shultz, PK | 1 |
| Strife, JL | 1 |
| Strife, CF | 1 |
| McDaniel, JD | 1 |
| Hernanz-Schulman, M | 1 |
| Grimm, P | 1 |
| Nowitzki, S | 1 |
| Classen, HG | 1 |
| Short, A | 1 |
| Shaw, NJ | 1 |
| Weindling, AM | 1 |
| Tsao, PW | 1 |
| Klip, A | 1 |
| Radde, IC | 1 |
| Myracle, MR | 1 |
| McGahan, JP | 1 |
| Goetzman, BW | 1 |
| Adelman, RD | 1 |
| Woolfield, N | 1 |
| Haslam, R | 1 |
| Le Quesne, G | 1 |
| Chambers, HM | 1 |
| Hogg, R | 1 |
| Jureidini, K | 1 |
| Kenney, IJ | 1 |
| Aiken, CG | 1 |
| Lenney, W | 1 |
| Atkinson, SA | 1 |
| Shah, JK | 1 |
| McGee, C | 1 |
| Steele, BT | 1 |
| Reuter, K | 1 |
| Kleinman, PK | 1 |
| DeWitt, T | 1 |
| Fabian, T | 1 |
| Levine, DZ | 1 |
| Roy, D | 1 |
| Tolnai, G | 1 |
| Nash, L | 1 |
| Shah, BG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Post-Cardiac Surgery Vitamin D Deficiency in Children With Congenital Heart Disease: A Pilot Dose Evaluation Randomized Controlled Trial[NCT01838447] | Phase 2 | 46 participants (Actual) | Interventional | 2013-07-31 | Completed | ||
| Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants[NCT00711763] | 1 participants (Actual) | Observational | 2008-07-31 | Terminated (stopped due to failure to recruit more patients and lack of supporting personnel.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Blood 25OHD will be measured to determine vitamin D deficiency, with a concentration below 50 nmol/L used to define deficiency. A PICU admission blood sample could not be obtained for one patient in the Usual Care Group and one patient in the High Dose Group, thus the total number analyzed differs from the full sample size. (NCT01838447)
Timeframe: 1 day (On admission to the pediatric intensive care unit (PICU) following CHD surgery)
| Intervention | nmol/L (Mean) |
|---|---|
| Usual Care Group | 34.8 |
| High Dose Group | 52.0 |
Hypercalcemia will be defined as an ionized calcium level above 1.40 mmol/L; or above 1.45 mmol/L for children under 8 weeks. Hypercalcemia will be evaluated in blood collected immediately before CHD surgery and throughout the post-operative course (measurements are standard of care). (NCT01838447)
Timeframe: Immediately before surgery, on admission to the PICU following CHD surgery, and on post-operative days 1,3,5 & 10
| Intervention | No. participants with hypercalcemia (Number) |
|---|---|
| Usual Care Group | 0 |
| High Dose Group | 0 |
Primarily, post-operative catecholamine requirements during the PICU admission will be evaluated as a dichotomous variable (yes/no). If a difference is noted in the primary analysis, inotrope requirements will be determined using the inotrope score, evaluated as the maximum score and in a time to event approach (off all inotropes, score of zero) (NCT01838447)
Timeframe: At any point between PICU admission and discharge, an average length of 5-7 days and not longer than 60 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Usual Care Group | 15 |
| High Dose Group | 11 |
Hypercalciuria will be identified using calcium:creatinine ratios defined using age-specific norms and thresholds. (NCT01838447)
Timeframe: Immediately before surgery, on admission to the PICU following CHD surgery, and on the first post-operative day
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Enrolment | Intra-operative | Post-Operative Day 1 | |
| High Dose Group | 0 | 4 | 1 |
| Usual Care Group | 1 | 3 | 2 |
2 reviews available for furosemide and Nephrocalcinosis
| Article | Year |
|---|---|
[Acute hypercalcemia as an oncological emergency. Pathogenesis, clinical aspects, therapy].
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Electrocardiography; Female; Fluid Therapy; | 1980 |
Nephrocalcinosis.
Topics: Furosemide; Humans; Hypophosphatemia, Familial; Infant; Nephrocalcinosis | 1997 |
1 trial available for furosemide and Nephrocalcinosis
| Article | Year |
|---|---|
The natural history of nephrocalcinosis in premature infants treated with loop diuretics.
Topics: Diuretics; Follow-Up Studies; Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Long | 1996 |
42 other studies available for furosemide and Nephrocalcinosis
| Article | Year |
|---|---|
Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural course.
Topics: Calcium; Case-Control Studies; Furosemide; Humans; Incidence; Infant; Infant, Newborn; Infant, Prema | 2022 |
Furosemide rescues hypercalciuria in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis model.
Topics: Animals; Calcium; Carrier Proteins; Claudins; Furosemide; Hypercalciuria; Magnesium; Mice; Nephrocal | 2023 |
Gitelman syndrome associated with chondrocalcinosis and severe neuropathy: a novel heterozygous mutation in SLC12A3 gene.
Topics: Aged; Chondrocalcinosis; Electromyography; Furosemide; Gitelman Syndrome; Glycyrrhiza; Humans; Hyper | 2020 |
[Nephrocalcinosis complicating miliary tuberculosis in an infant].
Topics: Furosemide; Glucocorticoids; Humans; Hypercalcemia; Infant; Male; Nephrocalcinosis; Tuberculosis, Mi | 2015 |
Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants.
Topics: Birth Weight; Calcium; Creatine; Diuretics; Female; Furosemide; Gestational Age; Humans; Infant, New | 2010 |
Renal calcification in very low birth weight infants.
Topics: Anti-Inflammatory Agents; Dexamethasone; Diuretics; Furosemide; Humans; Incidence; Infant, Newborn; | 2011 |
Furosemide-associated nephrocalcinosis and renal cysts.
Topics: Diagnosis, Differential; Diuretics; Female; Furosemide; Humans; Kidney Diseases, Cystic; Middle Aged | 2011 |
Development of an animal model of nephrocalcinosis via selective dietary sodium and chloride depletion.
Topics: Animals; Blood Pressure; Calcium; Chlorides; Disease Models, Animal; Furosemide; Kidney; Male; Nephr | 2013 |
An infant with multiple subcutaneous nodules, hypercalcemia, and nephrocalcinosis.
Topics: Biomarkers; Calcitriol; Calcium; Diuretics; Fat Necrosis; Fluid Therapy; Furosemide; Humans; Hyperca | 2013 |
Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat.
Topics: Aniline Compounds; Animals; Calcium; Furosemide; Hyperparathyroidism, Secondary; Kidney; Male; Nephr | 2004 |
Furosemide nephrolithiasis causing ureteral obstruction and urinoma in a preterm neonate.
Topics: Acute Kidney Injury; Diuretics; Female; Furosemide; Humans; Hyaline Membrane Disease; Hydronephrosis | 2004 |
Subcutaneous fat necrosis with hypercalcemia.
Topics: Administration, Oral; Bone Density Conservation Agents; Calcium; Diuretics; Etidronic Acid; Fat Necr | 2006 |
Sonographic diagnosis of furosemide-induced nephrocalcinosis in newborn infants.
Topics: Female; Furosemide; Heart Failure; Humans; Infant, Newborn; Male; Nephrocalcinosis; Ultrasonography | 1984 |
Pseudo-Bartter's syndrome due to furosemide abuse: report of a case and an analytical review of Japanese literature.
Topics: Adolescent; Adult; Aged; Bartter Syndrome; Calcium; Diagnosis, Differential; Female; Furosemide; Hum | 1981 |
Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide.
Topics: Female; Furosemide; Heart Failure; Humans; Infant; Infant, Newborn; Kidney Calculi; Male; Nephrocalc | 1994 |
Abnormal erythrocyte and renal frusemide-sensitive sodium transport in idiopathic calcium nephrolithiasis.
Topics: Adult; Biological Transport, Active; Chlorides; Erythrocytes; Female; Furosemide; Humans; Kidney; Ma | 1994 |
Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat.
Topics: Animals; Animals, Newborn; Calcium; Diuretics; Furosemide; Kidney; Longitudinal Studies; Male; Nephr | 1996 |
Salt supplementation, growth, and nephrocalcinosis in the furosemide-treated weanling rat.
Topics: Animals; Calcium; Electrolytes; Furosemide; Homeostasis; Nephrocalcinosis; Rats; Rats, Sprague-Dawle | 1997 |
Effect of diuretics on urinary oxalate, calcium, and sodium excretion in very low birth weight infants.
Topics: Analysis of Variance; Calcium; Diuretics; Furosemide; Gestational Age; Humans; Infant, Newborn; Infa | 1997 |
Nephrocalcinosis in rabbits--correlation of ultrasound, computed tomography, pathology and renal function.
Topics: Animals; Creatinine; Furosemide; Kidney; Nephrocalcinosis; Oxalates; Phosphates; Rabbits; Tomography | 1998 |
An infant with firm, fixed plaques.
Topics: Failure to Thrive; Fat Necrosis; Female; Fluid Therapy; Furosemide; Glucocorticoids; Humans; Hyperca | 1998 |
Effect of age on furosemide-induced nephrocalcinosis in the rat.
Topics: Aging; Animals; Calcium; Diuresis; Drinking; Eating; Furosemide; Male; Nephrocalcinosis; Rats; Rats, | 1998 |
Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up.
Topics: Calcium; Diuretics; Female; Furosemide; Heart Failure; Humans; Infant; Kidney; Male; Nephrocalcinosi | 1999 |
Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat.
Topics: Animals; Body Weight; Calcium; Chlorothiazide; Creatinine; Diuretics; Furosemide; Kidney; Male; Neph | 2000 |
Oxalate nephrocalcinosis in renal tubular dysgenesis.
Topics: Female; Fetal Death; Furosemide; Humans; Infant, Newborn; Kidney Tubules; Nephrocalcinosis; Oxalates | 1999 |
Persistent nephrocalcinosis for acetazolamide and furosemide in a pediatric patient.
Topics: Acetazolamide; Diuretics; Furosemide; Humans; Infant; Intracranial Hypertension; Nephrocalcinosis | 2000 |
Nephrocalcinosis induced by furosemide in an adult patient with incomplete renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Adult; Female; Furosemide; Humans; Nephrocalcinosis; Tomography, X-Ray Comp | 2001 |
Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle.
Topics: Adolescent; Adult; Calcium; Cations, Divalent; Child; Claudins; Diuretics; Family Health; Female; Fu | 2001 |
Medullary nephrocalcinosis associated with long-term furosemide abuse in adults.
Topics: Adult; Diuretics; Drug Administration Schedule; Female; Furosemide; Humans; Kidney Medulla; Male; Mi | 2001 |
Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years.
Topics: Absorption; Calcinosis; Calcium; Carbon Dioxide; Creatinine; Female; Furosemide; Humans; Infant; Inf | 1992 |
Furosemide-related renal calcifications in the premature infant. A longitudinal ultrasonographic study.
Topics: Child, Preschool; Female; Follow-Up Studies; Furosemide; Humans; Infant; Infant, Low Birth Weight; I | 1991 |
Hyperechoic renal medullary pyramids in infants and children.
Topics: Acidosis, Renal Tubular; Acute Kidney Injury; Adolescent; Bartter Syndrome; Calcium; Child; Child, P | 1991 |
Hyperechoic renal medullary pyramids in infants and children.
Topics: Child; Furosemide; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Kidney Diseases; Ki | 1991 |
Nephrocalcinosis without functional renal impairment in rats subjected to subacute moderate magnesium deficiency, and intervention studies on the mobilization of calcium deposits.
Topics: Animals; Bone and Bones; Calcium; Erythema; Female; Furosemide; Kidney; Kidney Calculi; Magnesium; M | 1990 |
Nephrocalcinosis and phosphate supplementation in a preterm infant.
Topics: Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Nephrocalcinosis; Phosphates | 1990 |
Furosemide increases total calcium in kidney and cytoplasmic free calcium in blood mononuclear cells of guinea pigs.
Topics: Analysis of Variance; Animals; Animals, Newborn; Calcium; Disease Models, Animal; Female; Furosemide | 1990 |
Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy.
Topics: Bone and Bones; Bone Diseases; Calcinosis; Chronic Disease; Furosemide; Humans; Infant; Infant, Low | 1986 |
Ultrasound diagnosis of nephrocalcinosis in preterm infants.
Topics: Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Nephrocalcinosis; Ultrasonography | 1988 |
Frusemide-induced nephrocalcinosis in very low birth weight infants.
Topics: Bronchopulmonary Dysplasia; Female; Furosemide; Humans; Infant, Low Birth Weight; Infant, Newborn; M | 1988 |
Mineral excretion in premature infants receiving various diuretic therapies.
Topics: Birth Weight; Bone Diseases, Metabolic; Diuretics; Drug Therapy, Combination; Female; Furosemide; Hu | 1988 |
Unsuspected medullary nephrocalcinosis from furosemide administration: sonographic evaluation.
Topics: Child; Female; Furosemide; Humans; Kidney Medulla; Nephrocalcinosis; Ultrasonography | 1985 |
Chloride depletion and nephrocalcinosis.
Topics: Alkalosis; Animals; Calcium; Chlorides; Diet; Drinking; Eating; Female; Furosemide; Kidney; Magnesiu | 1974 |